Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrix Bound Nanovesicles Modulatory Effect of Inflammation In Vitro in THP-1 Cells.

Pharmaceutics·2026
Same author

Matrix-bound nanovesicles as epigenetic modulators of myeloid cells.

Science advances·2026
Same author

Achilles tendinopathy.

Nature reviews. Disease primers·2025
Same author

Matrix-Bound Nanovesicles Promote Prohealing Immunomodulation Without Immunosuppression.

Tissue engineering. Part A·2025
Same author

Human Tendon-on-Chip: Unveiling the Effect of Core Compartment-T Cell Spatiotemporal Crosstalk at the Onset of Tendon Inflammation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2024
Same author

Advances, challenges, and future directions in the clinical translation of ECM biomaterials for regenerative medicine applications.

Advanced drug delivery reviews·2024

Related Experiment Video

Updated: Jan 14, 2026

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:17

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

788

Interfacing extracellular vesicles with bioengineered materials for regenerative medicine.

Kristiyan Stiliyanov-Atanasov1, Sara Bagur-Cardona1, Silvia Chiera1

  • 1Health Research Institute of the Balearic Islands (IdISBa), Palma 07120, Spain; Research Unit, Son Espases University Hospital (HUSE), Palma 07122, Spain; Group of Cell Therapy and Tissue Engineering (TERCIT), Research Institute on Health Sciences (IUNICS), University of the Balearic Islands (UIB), Ctra. Valldemossa km 7.5, Palma 07122, Spain.

Acta Biomaterialia
|October 16, 2025
PubMed
Summary

Extracellular vesicles (EVs) show promise in regenerative medicine. Integrating EVs with biomaterials improves their stability and targeting, overcoming limitations for enhanced therapeutic applications in tissue repair.

Keywords:
BiomaterialsExtracellular vesiclesHydrogelsPolymersRegenerative MedicineTissue engineering

More Related Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.3K
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.5K

Related Experiment Videos

Last Updated: Jan 14, 2026

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:17

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

788
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.3K
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.5K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Cell Biology

Background:

  • Extracellular vesicles (EVs) are potent cell-free therapeutics for regenerative medicine.
  • Clinical translation is hindered by rapid clearance and poor targeting of EVs.
  • Bioengineering offers solutions by integrating EVs with biomaterials.

Purpose of the Study:

  • To review strategies for interfacing EVs with biomaterials.
  • To discuss applications in tissue engineering and regenerative medicine.
  • To address challenges and solutions for clinical translation of EV-biomaterial hybrids.

Main Methods:

  • Analysis of literature on EV-biomaterial interfaces.
  • Examination of hydrogels, scaffolds, and implantable materials for EV integration.
  • Review of different EVs sources and immobilization techniques.

Main Results:

  • EVs integrated with biomaterials exhibit enhanced stability, bioavailability, and controlled release.
  • Various biomaterials (hydrogels, scaffolds) effectively host EVs.
  • Physical entrapment and covalent binding are key immobilization strategies.

Conclusions:

  • EV-biomaterial hybrids represent a paradigm shift in regenerative medicine.
  • This integration enhances EV therapeutic potential for tissue repair and functional recovery.
  • Overcoming translational challenges is crucial for advancing EV-based therapies.